All stock lists
Unlock the score
Cocrystal Pharma, Inc. (NASDAQ:COCP)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.97+0.02 (+2.31%)
Market cap
$18.7M
Insider Score
Analyst consensus
Listed since
Feb 22, 2012
Website
Insider Score
/ 100
COCP Insider Score
Cocrystal Pharma, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
COCP Stock Insider Trading Activity
COCP stock’s insider trading shows 2 purchases for an estimated $80.41K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days2 qualifying buys1 insider$80.41K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL Director | Buy | 10,000 | $0.98 | $9.82K | 0.5% | 1,993,551 | Aug 5, 2026 | FDilution | Form 4 |
| FROST PHILLIP MD ET AL Director | Buy | 75,000 | $0.94 | $70.59K | 3.9% | 1,983,551 | Aug 3, 2026 | DDilution | Form 4 |
| FROST PHILLIP MD ET AL Director | Buy | 20,000 | $1.00 | $20.00K | 1.1% | 1,908,551 | Feb 24, 2026 | DDilution | Form 4 |
| FROST PHILLIP MD ET AL Director | Buy | 50,000 | $0.95 | $47.50K | 2.7% | 1,888,551 | Feb 6, 2026 | DDilution | Form 4 |
| FROST PHILLIP MD ET AL Director | Buy | 50,000 | $0.95 | $47.50K | 2.8% | 1,838,551 | Dec 31, 2025 | DDilution | Form 4 |
| FROST PHILLIP MD ET AL Director | Buy | 20,000 | $0.97 | $19.40K | 1.1% | 1,788,551 | Dec 30, 2025 | DDilution | Form 4 |
| FROST PHILLIP MD ET AL Director | Buy | 40,000 | $0.97 | $38.80K | 2.3% | 1,768,551 | Dec 26, 2025 | CDilution | Form 4 |
| FROST PHILLIP MD ET AL Director | Buy | 25,000 | $0.97 | $24.25K | 1.5% | 1,728,551 | Dec 24, 2025 | DDilution | Form 4 |
| FROST PHILLIP MD ET AL Director | Buy | 1,500 | $1.00 | $1.50K | 0.1% | 1,701,051 | Nov 26, 2025 | DDilution | Form 4 |
| FROST PHILLIP MD ET AL Director | Buy | 2,500 | $0.99 | $2.48K | 0.1% | 1,703,551 | Nov 26, 2025 | DDilution | Form 4 |
| FROST PHILLIP MD ET AL Director | Buy | 20,000 | $0.94 | $18.80K | 1.2% | 1,699,551 | Nov 25, 2025 | CFirst BuyDilution | Form 4 |
| PFENNIGER RICHARD C JR Director | Award | 20,000 | — | — | 175% | 31,400 | Oct 28, 2025 | — | Form 4 |
| Martin James Joseph CEO | Award | 3,598 | $1.39 | $5.00K | 8.9% | 44,167 | Oct 28, 2025 | — | Form 4 |
| Hassan Fred Director | Award | 359,713 | $1.39 | $500.00K | 35.2% | 1,383,009 | Oct 28, 2025 | — | Form 4 |
| FROST PHILLIP MD ET AL Director | Award | 359,713 | $1.39 | $500.00K | 27.3% | 1,679,551 | Oct 28, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Award (A) — Grant or award from the company, not a purchase
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.